Home/Filings/4/0000905148-23-001510
4//SEC Filing

Joshi Manher 4

Accession 0000905148-23-001510

CIK 0001604464other

Filed

Nov 19, 7:00 PM ET

Accepted

Nov 20, 5:30 PM ET

Size

4.9 KB

Accession

0000905148-23-001510

Insider Transaction Report

Form 4
Period: 2023-11-16
Joshi Manher
EVP, Chief Medical Officer
Transactions
  • Sale

    Common Stock

    2023-11-16$0.39/sh12,287$4,780171,284 total
Footnotes (2)
  • [F1]Shares sold automatically to satisfy tax withholding obligations in connection with the vesting of previously granted restricted stock units, pursuant to a sale-to-cover provision in the award agreement.
  • [F2]The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on November 16, 2023 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employee.

Documents

1 file

Issuer

Atara Biotherapeutics, Inc.

CIK 0001604464

Entity typeother

Related Parties

1
  • filerCIK 0001978048

Filing Metadata

Form type
4
Filed
Nov 19, 7:00 PM ET
Accepted
Nov 20, 5:30 PM ET
Size
4.9 KB